Disease burden of herpes zoster in Korea

Journal of Clinical Virology

Volumn 47, Issue 4, 2010, Pages 325-329

  Choi, Won Suk ^a   Noh, Ji Yun ^a   Huh, Joong Yeon ^a   Jo, Yu Mi ^a   Lee, Jacob ^b   Song, Joon Young ^a   Kim, Woo Joo ^a   Cheong, Hee Jin ^a  

^a Korea University College of Medicine   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Disease burden; Herpes zoster; Varicella zoster virus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HEALTH CARE COST; HERPES ZOSTER; HOSPITALIZATION; HUMAN; INFANT; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; OUTPATIENT CARE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SOCIOECONOMICS;

ADOLESCENT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; HERPES ZOSTER; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; OFFICE VISITS; PREVALENCE; REPUBLIC OF KOREA; YOUNG ADULT;

EID: 77949491655     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.01.003     Document Type: Article

References (30)

1. Gnann Jr. J.W., and Whitley R.J. Clinical practice herpes zoster. N Engl J Med 347 (2002) 340-346
2. Katz J., Cooper E.M., Walther R.R., Sweeney E.W., and Dworkin R.H. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 39 (2004) 342-348
3. Donahue J.G., Choo P.W., Manson J.E., and Platt R. The incidence of herpes zoster. Arch Intern Med 155 (1995) 1605-1609
4. Choo P.W., Galil K., Donahue J.G., Walker A.M., Spiegelman D., and Platt R. Risk factors for postherpetic neuralgia. Arch Intern Med 157 (1997) 1217-1224
5. Yawn B.P., Saddier P., Wollan P.C., St. Sauver J.L., Kurland M.J., and Sy L.S. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 82 (2007) 1341-1349
6. Davies L., Cossins L., Bowsher D., and Drummond M. The cost of treatment for post-herpetic neuralgia in the UK. Pharmacoeconomics 6 (1994) 142-148
7. Sadzot-Delvaux C., Rentier B., Wutzler P., Asano Y., Suga S., Yoshikawa T., et al. Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis 197 Suppl. 2 (2008) S185-S190
8. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352 (2005) 2271-2284
9. Rothberg M.B., Virapongse A., and Smith K.J. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis 44 (2007) 1280-1288
10. Hornberger J., and Robertus K. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Ann Intern Med 145 (2006) 317-325
11. Edmunds W.J., Brisson M., and Rose J.D. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine 19 (2001) 3076-3090
12. Bartoloni A., Bartalesi F., Roselli M., Mantella A., Dini F., Carballo E.S., et al. Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia. Trop Med Int Health 7 (2002) 512-517
13. de Melker H., Berbers G., Hahne S., Rumke H., van den Hof S., de Wit A., et al. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine 24 (2006) 3946-3952
14. Kim Y.M., Lee S.Y., Lee J.S., Park Y.L., Whang K.U., Cho M.K., et al. Epidemiological and clinical study on herpes zoster in the province of Chungcheongnam-do (2004-2006). Korean J Dermatol 46 (2008) 1488-1494 [Korean]
15. Kang C.I., Choi C.M., Park T.S., Lee D.J., Oh M.D., and Choe K.W. Incidence of herpes zoster and seroprevalence of varicella-zoster virus in young adults of South Korea. Int J Infect Dis 12 (2008) 245-247
16. Song J.Y., Chung B.S., and Choi K.C. Shin BS. A 5-year period clinical observation on herpes zoster and the incidence of postherpetic neuralgia (2002-2006); a comparative analysis with the historical control group of a previous study (1995-1999). Korean J Dermatol 46 (2008) 431-436 [Korean]
17. Kang C.I., Choi C.M., Hong S.S., Kim H.B., Kim N.J., Oh M.D., et al. The incidence of herpes zoster in otherwise healthy young soldiers of Korean army. Infect Chemother 38 (2006) 45-46 [Korean]
18. Shin D.Y., and Koo D.W. Statistical analysis of herpes zoster in Chuncheon and the northern Kangwon province (1994-1996). Korean J Dermatol 36 (1998) 422-429 [Korean]
19. Park S.Y., Kim J.Y., Kim C.D., Kim C.W., and Lee K.S. A clinical study on herpes zoster during the last 10-year-period (1994-2003). Korean J Dermatol 42 (2004) 1531-1535 [Korean]
20. Korea National Stastical Office. Korean Statistical Information Service [Korean]. [cited 2008]; Available from: http://www.kosis.kr.
21. Jung Y.H., and Ko S.J. The socioeconomic cost of diseases in Koea. J Prev Med Public Health 39 (2006) 499-504 [Korean]
22. Park C.S., Kang H.Y., Kang D.R., and Jung H.Y. Cost-of-illness study of asthma in Korea: estimated from the Korea National Health Insurance claims database. J Prev Med Public Health 39 (2006) 397-403 [Korean]
23. Health Insurance Research Institute. Survey of medical charges paid by patients with health insurance in 2006 [Korean]. Seoul: National Health Insurance Corporation; 2007.
24. Ministry For Health Welfare and Family Affairs. The third Korean national health and nutrition examination survey (KNHANES III), 2005 [Korean]. Seoul: Korea Institute for Health and Social Affairs; 2006.
25. No I.C., Suh M.H., and Kim Y.L. Socioeconomic costs of alcohol and policy issues [Korean] (1997), Korea Institute of Health and Social Affairs, Seoul
26. van Hoek A.J., Gay N., Melegaro A., Opstelten W., and Edmunds W.J. Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales. Vaccine 27 (2009) 1454-1467
27. Stein A.N., Britt H., Harrison C., Conway E.L., Cunningham A., and Macintyre C.R. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine 27 (2009) 520-529
28. Di Legami V., Gianino M.M., Atti M.C., Massari M., Migliardi A., Tomba G.S., et al. Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine 25 (2007) 7598-7604
29. Hope-Simpson R.E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58 (1965) 9-20
30. Opstelten W.V.E.G., Schellevis F., Verheij T.J., and Moons K. Gender as an independent risk factor for herpes zoster: a population-based prospective. Ann Epidemiol 1006 (2006) 692-695